EPHA1 and laryngotracheoesophageal cleft: Over the past decade, a large number of original articles has been published on the role of different members of the EPH/ephrin system in the pathogenesis and progression of LC; moreover, these studies described their implication in (N)SCLC molecular pathways, immune evasion, metastasis, recurrence, and clinicopathological features, as well as patient survival and prognosis [21,22,23,24,25,26,27,28,29,30,31,32,33,34].